FDA Inspection 1018311 — Olymel S.E.C.
The FDA completed an inspection of Olymel S.E.C. on June 28, 2017 in Red Deer. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 28, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Red Deer (Canada)